B+
Bull case
25%
Probability
Target price
$110.00
+25.5% vs current
EW
Edwards LifesciencesCNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
55%
Probability
Target price
$95.00
+8.4% vs current
B-
Bear case
20%
Probability
Target price
$76.80
-12.4% vs current
AI sentiment snapshot
Latest data as of 2026-02-12
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+57.4
Score
AI commentary
Market tone is cautiously constructive: consensus analyst targets sit above the current anchor, indicating base-case upside while mixed results have prompted some downward revisions [#SERP-2][#SERP-3]. Newsflow and analyst action remain the primary near-term drivers, with sentiment hinging on quarterly performance and trial/regulatory updates [#SERP-6].
RankAlpha Sentiment AI - 2026-02-12
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-13catalystNext quarterly earnings reportHigh impact
Upcoming quarterly results will test revenue growth and margin trajectory after mixed Q4 commentary; EPS/margin beats or misses likely to drive near-term re-rating [#SERP-3].
2026-06-30eventAnalyst target revisions and coverage updatesHigh impact
Ongoing analyst revisions (downgrades/target cuts or upgrades) following results and guidance will shift 12-month consensus targets; monitor published updates [#SERP-2][#SERP-4].
2027-02-12catalystPivotal device/clinical readout or major regulatory milestoneHigh impact
Material trial readouts or regulatory approvals for transcatheter or surgical valve franchises could drive durable upside or downside; timing is longer-term and binary [#SERP-1].
Recommendation
N/A
No formal recommendation provided.
As of 2026-02-12 • Updated nightlySource: Internal modelMethodology